Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors

OBJECTIVE: Currently, serum chromogranin A is a well-established biomarker for pancreatic neuroendocrine tumors; however, other pancreatic diseases, oral use of a proton pump inhibitor and renal impairment can affect chromogranin A. Meanwhile, chromogranin B, belonging to the same granin family as c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Jpn J Clin Oncol
Auteurs principaux: Miki, Masami, Ito, Tetsuhide, Hijioka, Masayuki, Lee, Lingaku, Yasunaga, Kohei, Ueda, Keijiro, Fujiyama, Takashi, Tachibana, Yuichi, Kawabe, Ken, Jensen, Robert T., Ogawa, Yoshihiro
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283109/
https://ncbi.nlm.nih.gov/pubmed/28334992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyx032
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires